ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adolescent Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,151Medicare Part D Prescriptions Filled, Including Refills
$683K Total Retail Price of All Prescriptions
551 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 627 524
LISINOPRIL 447 382
METOPROLOL TARTRATE 437 363
WARFARIN SODIUM 388 356
AMLODIPINE BESYLATE 374 333
LEVOTHYROXINE SODIUM 368 327
RANITIDINE HCL 366 314
FUROSEMIDE 361 313
MIRTAZAPINE 324 300
NYSTATIN-TRIAMCINOLONE 297 221 10
OMEPRAZOLE 276 213
ATENOLOL 208 143
CITALOPRAM HBR 205 168
METFORMIN HCL 201 172
LACTULOSE 177 121
CARVEDILOL 168 150
GABAPENTIN 168 124
HYDRALAZINE HCL 158 122
SERTRALINE HCL 155 143
LEVETIRACETAM 154 90
DONEPEZIL HCL 154 141
QUETIAPINE FUMARATE 145 129
VALPROIC ACID 130 121
POTASSIUM CHLORIDE 123 92
TAMSULOSIN HCL 119 110
LANTUS 115 82
RISPERIDONE 115 82
ALBUTEROL SULFATE 112 93
DIVALPROEX SODIUM 110 101
NAMENDA 107 95
TRAZODONE HCL 106 100
DIGOXIN 103 96
CHLORHEXIDINE GLUCONATE 102 48
TRAVATAN Z 98 71
GLIPIZIDE 95 88
SEROQUEL 94 88
JANUVIA 91 76
OXYCODONE-ACETAMINOPHEN 89 73 S2
PREDNISONE 89 82
DIVALPROEX SODIUM ER 84 49
CARBIDOPA-LEVODOPA 82 78
LATANOPROST 81 69
OLANZAPINE 76 44
SILVER SULFADIAZINE 72 67
METOPROLOL SUCCINATE 70 59
FAMOTIDINE 70 58
LIDODERM 68 66
PHENYTOIN SODIUM EXTENDED 66 50
TRAMADOL HCL 64 52
ISOSORBIDE MONONITRATE ER 64 44
LOSARTAN POTASSIUM 60 46
FLUOCINONIDE 58 44
TAMIFLU 58 57
SYMBICORT 57 35
BACLOFEN 56 32
CLOPIDOGREL 55 53
SINGULAIR 54 39
SANTYL 52 46
POLYETHYLENE GLYCOL 3350 52 51
IPRATROPIUM BROMIDE 50 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.